Accessibility Menu
DNAPrint Genomics logo

DNAPrint Genomics

(OTC) DNAG

Current Price$0.00
Market Cap$600.00
Since IPO (1990)-100%
5 Year-99%
1 Year-83%
1 Month+0%

DNAPrint Genomics Financials at a Glance

Market Cap

$600.00

Revenue (TTM)

$1.93M

Net Income (TTM)

-$4.55M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

8.92 (High)

Price

$0.00

Volume

4,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 18, 2024

DNAG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About DNAPrint Genomics

Industry

Biotechnology

Headquarters

Sarasota, US

DNAG Financials

Key Financial Metrics (TTM)

Gross Margin

31%

Operating Margin

-4%

Net Income Margin

-5%

Return on Equity

0%

Return on Capital

3%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$600.00

Shares Outstanding

644.61M

Volume

4.00K

Avg. Volume

16.07K

Financials (TTM)

Gross Profit

$754.07K

Operating Income

-$8.87M

EBITDA

-$8.93M

Operating Cash Flow

-$5.78M

Capital Expenditure

-$391.45K

Free Cash Flow

-$6.17M

Cash & ST Invst.

$8.50M

Total Debt

$7.28M

DNAPrint Genomics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2007YOY CHG

Revenue

$227.56K

-65.1%

Gross Profit

-$6.59K

-103.0%

Gross Margin

-2.90%

N/A

Market Cap

$600.00

N/A

Market Cap/Employee

$25.00

N/A

Employees

24

N/A

Net Income

-$1.88M

+43.7%

EBITDA

-$1.51M

+31.8%

Quarterly Fundamentals

Name
Q3 2007YOY CHG

Total Cash

$134.35K

+21.3%

Total Debt

$5.33M

-21.0%

Accounts Receivable

$1.43M

+583.8%

Inventory

$289.16K

+47.6%

Long Term Debt

$259.54K

-40.2%

Short Term Debt

$5.07M

-19.7%

Return on Assets

-1.20%

N/A

Return on Invested Capital

2.53%

N/A

Free Cash Flow

-$1.36M

-2.6%

Operating Cash Flow

-$1.36M

-9.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IPAHInterpharm Holdings, Inc.
$0.00+0.00%
AVXTAVAX Technologies, Inc.
$0.00+0.00%
MHTXManhattan Scientifics, Inc.
$0.00+0.00%
BRAXFBraxia Scientific Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$160.95+0.19%
AALAmerican Airlines Group
$14.98+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%

Questions About DNAG

What is the current price of DNAPrint Genomics?

DNAPrint Genomics is trading at $0.00 per share.

What is the 52-week range for DNAPrint Genomics?

Over the past 52 weeks, DNAPrint Genomics has traded between $0.00 and $0.00.

How much debt does DNAPrint Genomics have?

DNAPrint Genomics total debt is unavailable.

How much cash does DNAPrint Genomics have on hand?

DNAPrint Genomics does not have cash on hand data available.

What is DNAPrint Genomics’s dividend yield?

DNAPrint Genomics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.